BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1129 related articles for article (PubMed ID: 12112477)

  • 21. Specificity and efficiency of Cre-mediated recombination in Emx1-Cre knock-in mice.
    Guo H; Hong S; Jin XL; Chen RS; Avasthi PP; Tu YT; Ivanco TL; Li Y
    Biochem Biophys Res Commun; 2000 Jul; 273(2):661-5. PubMed ID: 10873661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Generation and characterization of chondrocyte specific Cre transgenic mice].
    Hao ZM; Yang X; Cheng X; Zhou J; Huang CF
    Yi Chuan Xue Bao; 2002 May; 29(5):424-9. PubMed ID: 12043570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conditional gene activation in cultured hepatocytes using a ligand-dependent chimeric Cre recombinase.
    Zhu HZ; Cao YY; Cheng GX; Xue JL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 May; 35(5):435-40. PubMed ID: 12766804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Z/AP, a double reporter for cre-mediated recombination.
    Lobe CG; Koop KE; Kreppner W; Lomeli H; Gertsenstein M; Nagy A
    Dev Biol; 1999 Apr; 208(2):281-92. PubMed ID: 10191045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sertoli and granulosa cell-specific Cre recombinase activity in transgenic mice.
    Lécureuil C; Fontaine I; Crepieux P; Guillou F
    Genesis; 2002 Jul; 33(3):114-8. PubMed ID: 12124943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
    Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice.
    Xin HB; Deng KY; Rishniw M; Ji G; Kotlikoff MI
    Physiol Genomics; 2002 Sep; 10(3):211-5. PubMed ID: 12209023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial cell-specific expression of Cre recombinase in transgenic mice.
    Li WL; Cheng X; Tan XH; Zhang JS; Sun YS; Chen L; Yang X
    Yi Chuan Xue Bao; 2005 Sep; 32(9):909-15. PubMed ID: 16201233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Establishment of keratinocyte-specific Cre recombinase transgenic mice].
    Mao CM; Yang X; Cheng X; Lü YX; Zhou J; Huang CF
    Yi Chuan Xue Bao; 2003 May; 30(5):407-13. PubMed ID: 12924153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of a transgenic mouse in which Cre recombinase is expressed under control of the type II collagen promoter and doxycycline administration.
    Grover J; Roughley PJ
    Matrix Biol; 2006 Apr; 25(3):158-65. PubMed ID: 16386413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages.
    Georgiades P; Ogilvy S; Duval H; Licence DR; Charnock-Jones DS; Smith SK; Print CG
    Genesis; 2002 Dec; 34(4):251-6. PubMed ID: 12434335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Col1a1-driven transgenic markers of osteoblast lineage progression.
    Dacic S; Kalajzic I; Visnjic D; Lichtler AC; Rowe DW
    J Bone Miner Res; 2001 Jul; 16(7):1228-36. PubMed ID: 11450698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse.
    Schnütgen F; Doerflinger N; Calléja C; Wendling O; Chambon P; Ghyselinck NB
    Nat Biotechnol; 2003 May; 21(5):562-5. PubMed ID: 12665802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic expression of Cre recombinase in mitral/tufted cells of the olfactory bulb.
    Nagai Y; Sano H; Yokoi M
    Genesis; 2005 Sep; 43(1):12-6. PubMed ID: 16106355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RU486-inducible recombination in the salivary glands of lactoferrin promoter-driven green fluorescent Cre transgenic mice.
    Chen MR; Liu SW; Wu TC; Kao VY; Yu HC; Chen FH; Hsu CH; Chen CT; Lin KM
    Genesis; 2010 Oct; 48(10):585-95. PubMed ID: 20715174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice.
    Yamauchi Y; Abe K; Mantani A; Hitoshi Y; Suzuki M; Osuzu F; Kuratani S; Yamamura K
    Dev Biol; 1999 Aug; 212(1):191-203. PubMed ID: 10419695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An efficient system for tissue-specific overexpression of transgenes in podocytes in vivo.
    Moeller MJ; Soofi A; Sanden S; Floege J; Kriz W; Holzman LB
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F481-8. PubMed ID: 15784842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A transgenic mouse that targets the expression of Cre recombinase in pancreatic tissue.
    Zhou J; Cheng X; Lu YX; Huang CF; Yang X
    Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):286-90. PubMed ID: 12192858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VAChT-Cre. Fast and VAChT-Cre.Slow: postnatal expression of Cre recombinase in somatomotor neurons with different onset.
    Misawa H; Nakata K; Toda K; Matsuura J; Oda Y; Inoue H; Tateno M; Takahashi R
    Genesis; 2003 Sep; 37(1):44-50. PubMed ID: 14502577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.